Literature DB >> 11115462

Retrograde flow in the thoracic aorta in patients with systemic emboli: a transesophageal echocardiographic evaluation of mobile plaque motion.

A Tenenbaum1, M Motro, M S Feinberg, E Schwammenthal, C I Stroh, Z Vered, E Z Fisman.   

Abstract

STUDY
OBJECTIVES: Blood flow in the aorta is complex and incompletely characterized. Mobile aortic plaques (MAPs), moving freely with the pulsatile aortic flow, in fact represent natural tracers that reflect the flow pattern itself. Our aim was to use MAP motion on transesophageal echocardiography (TEE) in order to characterize flow patterns in the atheromatous thoracic aorta of patients with systemic emboli. DESIGN AND PATIENTS: The study group was recruited from 250 patients referred for TEE to evaluate recent embolism. Among them, 22 patients (14 men and 8 women; mean +/- SD age, 66.3 +/- 7.2 years; 16 patients with cerebrovascular and 6 patients with peripheral emboli) with MAPs of > or = 3 mm in length formed the study group. The longest amplitudes of three spatial components of mobile lesion motions were measured: x (antegrade/retrograde [A/R]), y (up/down [U/D], and z (right/left [R/L]).
RESULTS: A total of 33 mobile lesions were detected: 3 in the ascending aorta (1 patient), 13 in the arch (10 patients), and 17 in the descending aorta (11 patients). The length of mobile plaque components ranged from 3 to 13 mm; amplitudes of A/R, U/d, R/L, and retrograde flow motions ranged from 3 to 26 mm, from 1 to 16 mm, from 1 to 17 mm, and from 1 to 13 mm, respectively. Systolic rotational motion was clockwise in six patients (27%), counterclockwise in five patients (23%), incomplete (semicircle) in six patients (27%), and alternate clockwise/counterclockwise in five patients (23%). Diastolic rotational motion was clockwise in 5 patients (23%), counterclockwise in 6 patients (27%), and incomplete (semicircle) in 11 patients (50%). There were 18 multiple MAPs in seven patients: in all these cases, simultaneous rotations of MAP in different directions (as a marker for the presence of multiple vortices) were found. In nine patients with cerebral embolism, MAPs on the distal part of aortic arch solely were found; in five of them, all alternative potential sources of stroke were excluded. Therefore, retrograde cerebral embolism from distal aortic plaques in these patients is highly probable.
CONCLUSIONS: Retrograde and rotational blood flow in the thoracic aorta probably exists in all patients with systemic emboli and mobile protruding aortic atheromas. Therefore, retrograde cerebral embolism from distal aortic plaques is theoretically possible.

Entities:  

Mesh:

Year:  2000        PMID: 11115462     DOI: 10.1378/chest.118.6.1703

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  [Diagnosing stroke aetiologies. Morphologic and functional analysis of the aorta and carotid arteries by MRI].

Authors:  A Harloff; M Markl; A Frydrychowicz; J Hennig; C Weiller
Journal:  Nervenarzt       Date:  2009-08       Impact factor: 1.214

2.  Retrograde embolism from the descending thoracic aorta causing stroke: an underappreciated clinical condition.

Authors:  Lovely Chhabra; Rabin Niroula; Jayant Phadke; David H Spodick
Journal:  Indian Heart J       Date:  2013-04-09

3.  Atherosclerotic aortic arch plaques in acute ischemic stroke.

Authors:  Randa Deif; Mohamed El-Sayed; Foad Abd Allah; Essam Baligh; Nervana M El-Fayomy; Loai Ezzat; Heba Gamal
Journal:  J Vasc Interv Neurol       Date:  2011-01

4.  Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study.

Authors:  Cesare Russo; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

5.  Retrograde blood flow in the aortic arch determined by transesophageal Doppler ultrasound.

Authors:  S Svedlund; R Wetterholm; R Volkmann; K Caidahl
Journal:  Cerebrovasc Dis       Date:  2008-11-15       Impact factor: 2.762

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.